OR WAIT null SECS
Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023
The sixth annual Serialization Readiness Survey, a poll of manufacturers and distributors, is out from the Healthcare Distribution Alliance (HDA). As in past years, the main worries are how broadly manufacturers are readying their IT systems to convey required transaction data to their trading partners—specifically, wholesaler-distributors. The worries of early years, in getting readable barcodes on individual packages, have faded but not disappeared. All this is happening in the context (in the US) of the Drug Supply Chain Security Act (DSCSA), which has a November 2023 deadline for a fully interoperable, electronic data-sharing system that can track individual pharmaceutical packages from point of origin to point of dispensing.
Key findings of the 2021 survey, which involved a relatively small number of manufacturers (around 40) and distributors (25) responding last May:
“The uneven state of readiness among supply chain partners has likely been exacerbated by operating under the pressures of the Covid-19 response,” notes Perry Fri, EVP, industry relations for HDA. “However, our findings also illustrate the range of interpretations and information gaps that must be overcome within the next two years. Educating trading partners, such as the dispenser community, and aligning on requirements will be crucial to getting implementation over the finish line.”
This year’s survey was sponsored by LSPediA and Movilitas, two solution providers.